Clinical Investigation of the Freedom SOLO Stentless Heart Valve

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:

18 Years and older (Adult, Senior)

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

No

Criteria

Inclusion Criteria:

The patient is male or female 18 years old or older.

The patient is willing to sign the informed consent.

The patient which preoperative evaluation indicated the need for native or prosthetic aortic valve replacement.

Any patient amenable to aortic valve replacement with biological prosthesis should be enrolled in the study, even in conjunction with valve repair, coronary artery bypass grafting and other procedures.

The patient is located in a geographic location that will enable the subject to return to the study site for all follow-up examinations (i.e. geographically stable).

Patient will be available to the investigator(s) for postoperative follow-up beyond one year.

Exclusion Criteria:

The patient has preexisting valve prosthesis in the mitral, pulmonary or tricuspid position.

The patient requires a double or triple valve replacement (a valve repair is not considered an exclusion criterion).

The patient has a previously implanted SOLO valve, within the clinical study, that requires replacement.

The patient has active endocarditis.

The patient is or will be participating in a concomitant research study of an investigational product.

The patient is a minor, intravenous drug user, alcohol abuser, prisoner, institutionalized, or is unable to give informed consent.

The patient has a major or progressive non-cardiac disease that, in the investigator's experience, results in a life expectancy of less than 1 year, or the implant of the device produces an unacceptable increased risk to the patient.

The patient is pregnant or lactating.

Patients with congenital bicuspid aortic valve.

Patients are known to be noncompliant or are unlikely to complete the study.